PEDF, a member of the serine protease inhibitor superfamily (SERPINs), showed increased levels in the AH of glaucoma patients compared to healthy subjects, while it is a prominent down-regulated marker in different tissues in neovascular eye diseases such as AMD [64] or DR [65]. Here, SERPINF1 is linked to glaucoma.